PHIBRO ANIMAL HEALTH CORP (PAHC)
NASDAQ · Pharmaceuticals & Biotech · Pharmaceutical Preparations
- Price
- $34.10
- Day
- -2.99%
- Market cap
- $1.4B
- P/E
- 14.7
Close 2026-09-23.
The company
Overview Phibro Animal Health Corporation is a leading global diversified animal health and mineral nutrition company. We strive to be a trusted partner with livestock producers, farmers, veterinarians and consumers who raise and care for farm and companion animals by providing solutions to help them maintain and enhance the health of their animals. We market approximately 790 product lines in approximately 90 countries to approximately 4,800 customers. We develop, manufacture and market a broad range of products for food animals including poultry, beef and dairy cattle, swine, aquaculture and dogs. Our products help prevent, control and treat diseases and support nutrition to help improve animal health and well-being. We sell animal health and mineral nutrition products either directly to integrated poultry, cattle and swine producers or through animal feed manufacturers, wholesalers, distributors and veterinarians.
From Item 1: Overview.
By product & service
- Medicated Feed Additives and Others — 50%
- Mineral Nutrition — 20%
- Nutritional Specialties — 14%
- Vaccines — 11%
- Performance Products — 6%
Institutional holders
Largest positions reported on Form 13F for the quarter ended 2026-06-30, by value.
- BlackRock, Inc. — $73.63M
- FMR LLC — $68.37M
- STATE STREET CORP — $32.61M
- MILLENNIUM MANAGEMENT LLC — $29.41M
- VANGUARD CAPITAL MANAGEMENT LLC — $28.99M
- FMR LLC — $23.83M
- BlackRock, Inc. — $18.3M
- GEODE CAPITAL MANAGEMENT, LLC — $18.24M
Insider trades
Open-market buys and sales filed on Form 4, newest first. Grants, option exercises and tax withholding are left out.
- CORCORAN E THOMAS (Director) bought 10,000 shares at $31.77 on 2026-05-29
- BENDHEIM JACK (President and CEO) sold 2,029 shares at $49.19 on 2026-05-07
- BENDHEIM JACK (President and CEO) sold 1,149 shares at $48.31 on 2026-05-07
- BENDHEIM JACK (President and CEO) sold 1,350 shares at $47.59 on 2026-05-07
- BENDHEIM JACK (President and CEO) sold 5,634 shares at $57.18 on 2026-05-06
- BENDHEIM JACK (President and CEO) sold 1,406 shares at $58.13 on 2026-05-06
Recent filings
- ARS — 2026-09-18
- DEF 14A — 2026-09-18
- DEFA14A — 2026-09-18
- 4/A — 2026-09-17
- 4/A — 2026-09-17
- 144 — 2026-09-16
- 10-K — 2026-08-26
- 8-K — 2026-08-26
- 4 — 2026-08-10
- 4 — 2026-08-10